Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast to 2026

呼吸ケア装置の世界市場予測:製品別、エンドユーザー別

◆タイトル:Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast to 2026
◆商品コード:MD1583
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年10月25日
◆ページ数:423
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は呼吸ケア装置の世界市場規模が2021年184億ドルから2026年276億ドルまで、年平均8.5%成長すると予想しています。本書では、世界の呼吸ケア装置市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、製品別(治療用呼吸ケア装置、監視装置、診断呼吸ケア装置、消耗品・付属品)分析、疾患別(慢性閉塞性肺疾患(COPD)、睡眠時無呼吸、喘息、感染症、その他)分析、エンドユーザー別(病院、在宅医療、外来ケアセンター(ACCS))分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・呼吸ケア装置の世界市場規模:製品別(治療用呼吸ケア装置、監視装置、診断呼吸ケア装置、消耗品・付属品)
・呼吸ケア装置の世界市場規模:疾患別(慢性閉塞性肺疾患(COPD)、睡眠時無呼吸、喘息、感染症、その他)
・呼吸ケア装置の世界市場規模:エンドユーザー別(病院、在宅医療、外来ケアセンター(ACCS))
・呼吸ケア装置の世界市場規模:地域別
・競争状況
・企業情報

“The respiratory care devices market is expected to reach USD 27.6 billion by 2026 from USD 18.4 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.”
Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. The major factor driving the growth of the respiratory care devices market is the high prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population, high prevalence of tobacco smoking, urbanization and growing levels of pollution, and changing lifestyle. However, factors such as the presence of an unfavorable reimbursement scenario and the availability of low-cost products from local manufacturers are expected to restrain the growth of this market during the forecast period.

“COPD segment is anticipated to witness the fastest growth during the forecast period.”
COPD is a medical term referring to a group of lung diseases, including chronic bronchitis and emphysema. It is an inflammatory and progressive life-threatening lung disease characterized by a persistent blockage of airflow from the lungs. One of the major causes of COPD is tobacco smoking. According to the US CDC, as many as eight in 10 COPD-related deaths are due to smoking. Additionally, rising indoor (biomass fuel) and outdoor air pollution levels, exposure to dust and chemicals (vapors, irritants, and fumes), genetic disorders, and increasing geriatric population are other factors driving the prevalence of COPD. The elements, as mentioned above, are expected to drive the demand for respiratory care devices during the forecast period.

“Hospitals is the largest end-user segment in the respiratory care devices market in 2020.”
Based on end-user, the respiratory care devices market is divided into hospitals, home care settings and ambulatory care. Hospitals form the largest end-user segment of the respiratory care devices market. This can largely be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Hospitals provide respiratory care services to patients through various departments, such as intensive care units, emergency rooms, outpatient departments, and pulmonary diagnostic laboratories, among others. Moreover, COVID-19 has tremendously impacted o the hospital segment. Several hospitals have been established in order to cure an increasing number of patients infected from the coronavirus.

“North America will continue to dominate the respiratory care devices market in 2026.”
The respiratory care devices market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the respiratory care devices market. The large share of North America in this market can be attributed to the outbreak of COVID-19, which has driven the demand for respiratory devices in North America. Due to its growing geriatric population segment and environmental conditions that have favored the spread of the disease, COVID-19 has severely affected the region and ensured enormous growth in the demand for respiratory care devices. Players in this and adjacent, or even non-related, markets have focused on or collaborated for expanding the manufacturing of critical care instruments and respiratory care devices.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 35%, Tier 2: 40%, and Tier 3: 28%
• By Designation – C-level: 20%, Director-level: 35%, and Others: 45%
• By Region – North America: 30%, Europe: 27%, Asia Pacific: 25%, Latin America: 10%, and the Middle East & Africa: 8%

Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare (New Zealand), Drager AG (Germany), Invacare Corporation (US), Nihon Kohden (Japan), Getinge AB (Sweden), Air Liquide (France).

Research Coverage:
The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of various market segments, based on type, indication, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the respiratory care devices market. The report analyzes this market by type, indication, end user, and region.
 Market Development: Comprehensive information on the lucrative emerging markets, by type, indication, end user, and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the respiratory care devices market.
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the respiratory care devices market.

【レポートの目次】

1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION AND SCOPE 34
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.2.2 MARKETS COVERED 35
FIGURE 1 RESPIRATORY CARE DEVICES SEGMENTATION 35
FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION 35
1.2.3 YEARS CONSIDERED FOR THE MARKET STUDY 36
1.3 CURRENCY 36
TABLE 1 THE ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY CONVERSIONS TO USD 36
1.4 STAKEHOLDERS 37
1.5 LIMITATIONS 37
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 3 RESEARCH DESIGN 39
2.1.1 SECONDARY RESEARCH 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY RESEARCH 41
FIGURE 4 PRIMARY SOURCES 41
2.1.2.1 Key data from primary sources 42
2.1.2.2 Key industry insights 43
TABLE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 44
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 44
2.2 MARKET SIZE ESTIMATION 45
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 45
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC 46
FIGURE 9 SUPPLY-SIDE ANALYSIS: RESPIRATORY CARE DEVICES MARKET (2020) 47
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE RESPIRATORY CARE DEVICES MARKET (2021–2026) 48
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 12 TOP-DOWN APPROACH 49
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 50
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ASSUMPTIONS 51
FIGURE 14 ASSUMPTIONS FOR THE STUDY 51
2.5 RISK ASSESSMENT 52
TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET 52
3 EXECUTIVE SUMMARY 53
FIGURE 15 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 54
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, DISEASE INDICATIONS,
2021 VS. 2026 (USD MILLION) 55
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 56
FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET 57
4 PREMIUM INSIGHTS 58
4.1 RESPIRATORY CARE DEVICES MARKET: MARKET OVERVIEW 58
FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD 58
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, 2020 59
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE RESPIRATORY CARE DEVICES MARKET IN NORTH AMERICA IN 2020 59
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 22 CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 60
4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX 60
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESPIRATORY CARE DEVICES MARKET DURING THE FORECAST PERIOD 60
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 61
FIGURE 24 DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
FIGURE 25 MARKET DYNAMICS: IMPACT ANALYSIS 62
5.2 MARKET DRIVERS 63
5.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES 63
5.2.1.1 Rapid growth in the global geriatric population 64
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 64
5.2.1.2 Urbanization and growing pollution levels 64
FIGURE 27 DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE (~EVERY YEAR) 65
5.2.1.3 High prevalence of tobacco smoking 65
TABLE 4 PREVALENCE AND DEATHS CAUSED DUE TO LIFESTYLE DISEASES 65
5.2.1.4 Changing lifestyles 65
5.2.2 INCREASING INCIDENCE RATE OF PRETERM BIRTHS 66
TABLE 5 THE 10 COUNTRIES WITH THE HIGHEST NUMBER OF PRETERM BIRTHS 66
TABLE 6 THE 10 COUNTRIES WITH THE HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS 67
5.2.3 OUTBREAK OF INFECTIOUS DISEASES AFFECTING THE RESPIRATORY SYSTEM 67
5.2.4 UNDERPENETRATED MARKETS IN SLEEP AND COPD 67
5.2.5 FOCUS ON IMPROVING PATIENT OUTCOMES 68
5.2.6 RISING R&D INVESTMENTS RESULTING IN TECHNOLOGICALLY ADVANCED DEVICES 68
TABLE 7 PRODUCT LAUNCHES 69
FIGURE 28 R&D EXPENDITURE (% OF TOTAL REVENUE) BY KEY PLAYERS (2020 VS 2019) 69
5.3 MARKET RESTRAINTS 69
5.3.1 UNFAVORABLE REIMBURSEMENT SCENARIO 69
5.3.2 AVAILABILITY OF LOW-COST PRODUCTS FROM LOCAL MANUFACTURERS 70
5.3.3 HIGH COST OF CPAP MACHINES 70
5.4 MARKET OPPORTUNITIES 71
5.4.1 GROWING DEMAND FOR HOME CARE THERAPEUTIC DEVICES 71
5.4.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS THE ASIA PACIFIC AND LATIN AMERICA 71
5.4.3 POINT-OF-CARE DIAGNOSTICS 72
5.4.4 GROWING AWARENESS ABOUT THE ILL-EFFECTS OF UNTREATED SLEEP APNEA 72
TABLE 8 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA 73
5.5 MARKET CHALLENGES 74
5.5.1 LOW AWARENESS AND A LARGE UNDERDIAGNOSED AND UNDERTREATED POPULATION 74
5.5.2 HARMFUL EFFECTS OF CERTAIN DEVICES ON NEONATES 74
5.5.3 LACK OF PATIENT COMPLIANCE 75
6 INDUSTRY INSIGHTS 76
6.1 INDUSTRY TRENDS 76
6.1.1 RISING DEMAND FOR ENHANCED COMPACT & PORTABLE DEVICES 76
6.1.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSIONS 76
6.1.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 76
6.1.4 RISING ADOPTION OF NONINVASIVE VENTILATION 77
FIGURE 29 IMPACT ON PATIENT’S LIVES WITH THE INTRODUCTION OF INNOVATIVE SOLUTIONS FOR UNMET PATIENT NEEDS 77
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS LOWERING THE OVERALL COSTS FOR SLEEP APNEA TREATMENT 77
6.2 REGULATORY ANALYSIS 78
6.2.1 NORTH AMERICA 78
6.2.1.1 US 78
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT 78
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 78
6.2.1.2 Canada 79
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 79
6.2.1.3 Europe 79
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 80
6.2.1.4 Asia Pacific 80
6.2.1.4.1 Japan 80
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 81
6.2.1.4.2 China 81
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 81
6.2.1.4.3 India 82
6.3 ECOSYSTEM ANALYSIS 82
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS 83
6.4 VALUE CHAIN ANALYSIS 83
FIGURE 32 VALUE CHAIN: RESPIRATORY CARE DEVICES MARKET 84
6.5 COVID-19 IMPACT ON THE RESPIRATORY CARE DEVICES MARKET 84
6.6 TECHNOLOGY TRENDS 85
6.6.1 E-NOSE TECHNOLOGY 85
6.6.2 MEMS TECHNOLOGY 85
6.6.3 ELECTROCHEMICAL TECHNOLOGY 85
6.6.4 WIRELESS GAS SENSOR TECHNOLOGY 85
6.7 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET 86
6.7.1 INTRODUCTION 86
6.7.2 THE FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE 86
6.7.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 87
6.7.4 COVID-19 TO DRIVE THE DEMAND FOR ARTIFICIAL INTELLIGENCE IN VENTILATORS 87
6.8 SENSOR TECHNOLOGIES IN VENTILATORS 88
6.8.1 INTRODUCTION 88
6.8.2 FLOW SENSORS 88
6.8.3 OXYGEN SENSORS 89
6.8.4 PRESSURE SENSORS 89
6.9 PATENT ANALYSIS 90
6.9.1 PATENT PUBLICATION TRENDS 90
FIGURE 33 PATENT PUBLICATION TRENDS: 2010 TO 2021 90
6.9.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR RESPIRATORY CARE DEVICE PATENTS 91
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICE PATENTS 91
FIGURE 34 JURISDICTION ANALYSIS FOR THE US (2014-2021) 91
6.10 TRADE ANALYSIS 91
TABLE 16 TOP EXPORTERS OF MEDICAL VENTILATORS; CPAP; BIPAP; OXYGEN CONCENTRATORS, 2018 (IN USD MN) 92
TABLE 17 INDIA THERAPEUTIC RESPIRATION APPARATUS; OZONE, OXYGEN, AEROSOL THERAPY APPARATUS; ARTIFICIAL RESPIRATION OR OTHER THERAPEUTIC RESPIRATION APPARATUS EXPORTS BY COUNTRY, 2019 (IN 000’) 92
6.11 YC-YCC SHIFT: RESPIRATORY CARE DEVICES MARKET 93
FIGURE 35 YC-YCC SHIFT IN THE RESPIRATORY CARE DEVICES MARKET 93
6.12 CASE STUDIES 94
TABLE 18 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES 94
TABLE 19 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES AND SPIROMETERS 94
6.13 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 20 PORTER’S FIVE FORCES ANALYSIS 95
6.13.1 THREAT OF NEW ENTRANTS 95
6.13.2 THREAT OF SUBSTITUTES 96
6.13.3 BARGAINING POWER OF MANUFACTURERS 96
6.13.4 BARGAINING POWER OF BUYERS 96
6.13.5 INTENSITY OF COMPETITIVE RIVALRY 96
7 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 97
7.1 INTRODUCTION 98
TABLE 21 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 98
TABLE 22 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
7.2 THERAPEUTIC RESPIRATORY CARE DEVICES 99
TABLE 23 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 24 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
7.2.1 PAP DEVICES 101
TABLE 25 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 101
TABLE 26 PAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
7.2.1.1 CPAP devices 102
7.2.1.1.1 Significantly effective in treating severe and moderate OSA 102
TABLE 27 CPAP DEVICES AVAILABLE IN THE MARKET 103
TABLE 28 CPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
7.2.1.2 APAP devices 104
7.2.1.2.1 Sleep apnea patients who struggle to breathe out with a CPAP device find it easier to breathe using APAP devices 104
TABLE 29 APAP DEVICES AVAILABLE IN THE MARKET 104
TABLE 30 APAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
7.2.1.3 BiPAP devices 105
7.2.1.3.1 BiPAP machines have important capabilities in the treatment of COVID-19 105
TABLE 31 BIPAP DEVICES AVAILABLE IN THE MARKET 106
TABLE 32 BIPAP DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
7.2.2 VENTILATORS 106
TABLE 33 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 34 VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.2.2.1 ICU ventilators 108
TABLE 35 ICU VENTILATORS AVAILABLE IN THE MARKET 108
TABLE 36 ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 37 ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
7.2.2.1.1 High-end ventilators 110
7.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive the adoption of high-end ventilators in developing countries 110
TABLE 38 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.2.2.1.2 Mid-end ventilators 111
7.2.2.1.2.1 Mid-end ventilators are mainly used in large and medium-sized hospitals and ambulatory care settings 111
TABLE 39 MID-END VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
7.2.2.1.3 Basic ventilators 112
7.2.2.1.3.1 Basic ventilators are the most preferred for predetermined and long-term ventilation in long-term care centers, home care, and ambulatory care centers 112
TABLE 40 BASIC VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
7.2.2.2 Portable/transportable ventilators 113
7.2.2.2.1 The increasing demand for home care is driving the adoption of portable/transportable ventilators 113
TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS AVAILABLE IN THE MARKET 114
TABLE 42 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
7.2.3 NEBULIZERS 115
7.2.3.1 Nebulizers are more effective compared to oral dosages 115
TABLE 43 NEBULIZERS AVAILABLE IN THE MARKET 116
TABLE 44 NEBULIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
7.2.4 HUMIDIFIERS 118
TABLE 45 HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 46 HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
7.2.4.1 Heated humidifiers 119
7.2.4.1.1 Ease of control and customizability drives the market growth for heated humidifiers 119
TABLE 47 HEATED HUMIDIFIERS AVAILABLE IN THE MARKET 120
TABLE 48 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
7.2.4.2 Passover humidifiers 121
7.2.4.2.1 Passover humidifiers inhibit the customization of the amount of moisture delivered to patients 121
TABLE 49 PASSOVER HUMIDIFIERS AVAILABLE IN THE MARKET 121
TABLE 50 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
7.2.5 OXYGEN CONCENTRATORS 122
TABLE 51 OXYGEN CONCENTRATORS AVAILABLE IN THE MARKET 123
TABLE 52 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 53 OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.5.1 Fixed oxygen concentrators 124
7.2.5.1.1 Fixed oxygen concentrators are less expensive compared to portable oxygen concentrators 124
TABLE 54 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.5.2 Portable oxygen concentrators 125
7.2.5.2.1 Low weight and portability to drive the growth of this segment 125
TABLE 55 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
7.2.6 INHALERS 127
TABLE 56 INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 57 INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
7.2.6.1 Metered-dose inhalers (MDIs) 128
7.2.6.1.1 MDIs are the most widely adopted inhalers among patients 128
TABLE 58 METERED-DOSE INHALERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.2.6.2 Dry powder inhalers (DPIs) 129
7.2.6.2.1 Lower clinical efficiency and dose variations in DPIs to restrain the market growth 129
TABLE 59 DRY POWDER INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
7.2.7 REUSABLE RESUSCITATORS 130
7.2.7.1 Reusable resuscitators are economical and can be disassembled, cleaned, or reassembled as per convenience 130
TABLE 60 REUSABLE RESUSCITATORS OFFERED BY MAJOR PLAYERS 131
TABLE 61 REUSABLE RESUSCITATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 62 REUSABLE RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 132
TABLE 63 ADULT RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 64 INFANT/NEONATAL RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 134
7.2.8 NITRIC OXIDE DELIVERY UNITS 134
7.2.8.1 Strong focus on developing innovative and advanced nitric oxide delivery units to boost its adoption in the coming years 134
TABLE 65 NITRIC OXIDE DELIVERY UNITS OFFERED BY MAJOR PLAYERS 135
TABLE 66 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.2.9 OXYGEN HOODS 136
7.2.9.1 The growing prevalence and recurrence of chronic lung diseases is expected to support the market growth for oxygen hoods 136
TABLE 67 OXYGEN HOODS OFFERED BY MAJOR PLAYERS 136
TABLE 68 OXYGEN HOODS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.3 MONITORING DEVICES 137
TABLE 69 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 70 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.3.1 PULSE OXIMETERS 138
TABLE 71 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS 139
TABLE 72 PULSE OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 73 PULSE OXIMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
7.3.1.1 Pulse oximeter sensors 140
7.3.1.1.1 The use of disposable pulse oximeter sensors reduces the risk of cross-contamination and HAIs 140
TABLE 74 PULSE OXIMETER SENSORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
7.3.1.2 Pulse oximeter equipment 141
7.3.1.2.1 The rising adoption of pulse oximeter equipment in home care settings is projected to drive the market growth 141
TABLE 75 PULSE OXIMETER EQUIPMENT OFFERED BY MAJOR PLAYERS 142
TABLE 76 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
7.3.2 CAPNOGRAPHS 143
7.3.2.1 Extensive research in capnography has led to the development of advanced capnographs 143
TABLE 77 CAPNOGRAPHS OFFERED BY MAJOR PLAYERS 143
TABLE 78 CAPNOGRAPHS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 144
7.3.3 GAS ANALYZERS 144
7.3.3.1 Increasing demand for point-of-care testing to drive the demand for portable gas analyzers 144
TABLE 79 GAS ANALYZERS OFFERED BY MAJOR PLAYERS 145
TABLE 80 GAS ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 146
TABLE 81 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 82 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
7.4.1 SPIROMETERS 147
7.4.1.1 Rising technological advancements in this segment to increase the adoption of spirometers 147
TABLE 83 SPIROMETERS OFFERED BY MAJOR PLAYERS 147
TABLE 84 SPIROMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
7.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 148
7.4.2.1 Rising incidence of obstructive sleep apnea to drive the growth for PSG devices 148
TABLE 85 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 149
TABLE 86 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
7.4.3 PEAK FLOW METERS 150
7.4.3.1 Peak flow meters are not preferred in hospitals due to the high variability in measurements obtained from these devices 150
TABLE 87 PEAK FLOW METERS OFFERED BY VARIOUS PLAYERS 150
TABLE 88 PEAK FLOW METERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 151
7.4.4 OTHER DIAGNOSTIC DEVICES 151
TABLE 89 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
7.5 CONSUMABLES & ACCESSORIES 152
TABLE 90 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 91 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 153
7.5.1 MASKS 154
TABLE 92 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 93 MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 155
7.5.1.1 Reusable masks 155
7.5.1.1.1 Rising ICU hospital admissions during the COVID-19 pandemic to drive the adoption of reusable masks 155
TABLE 94 REUSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.5.1.2 Disposable masks 156
7.5.1.2.1 Increasing patient population for respiratory diseases to drive the growth of this segment 156
TABLE 95 DISPOSABLE MASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
7.5.2 DISPOSABLE RESUSCITATORS 157
7.5.2.1 Technologically advanced valves in resuscitators to drive the market growth during the forecast period 157
TABLE 96 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
7.5.3 TRACHEOSTOMY TUBES 158
7.5.3.1 Introduction of new and advanced products with ergonomic designs to drive the market growth 158
TABLE 97 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 159
7.5.4 BREATHING CIRCUITS 159
7.5.4.1 The outbreak of COVID-19 has driven the rising demand for breathing circuits 159
TABLE 98 BREATHING CIRCUITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
7.5.5 NASAL CANNULAE 160
7.5.5.1 Increasing focus on minimally invasive surgery techniques is expected to boost the demand for nasal cannulae 160
TABLE 99 NASAL CANNULAE MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 161
7.5.6 OTHER CONSUMABLES & ACCESSORIES 162
TABLE 100 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
8 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS 163
8.1 INTRODUCTION 164
TABLE 101 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2019–2026 (USD MILLION) 164
8.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 164
8.2.1 THE INCREASING PREVALENCE OF COPD DRIVES THE DEMAND FOR RESPIRATORY CARE DEVICES 164
TABLE 102 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY,
2019–2026 (USD MILLION) 165
8.3 SLEEP APNEA 165
8.3.1 RISING AWARENESS FOR SLEEP APNEA DIAGNOSIS TO DRIVE THE DEMAND FOR RESPIRATORY CARE DEVICES 165
TABLE 103 INCREASING PREVALENCE OF SLEEP APNEA TO RAISE AWARENESS FOR ITS DIAGNOSIS 166
TABLE 104 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2019–2026 (USD MILLION) 167
8.4 ASTHMA 168
8.4.1 INCREASING GLOBAL BURDEN OF ASTHMA TO SUPPORT THE MARKET GROWTH 168
TABLE 105 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY,
2019–2026 (USD MILLION) 169
8.5 INFECTIOUS DISEASES 169
8.5.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE THE MARKET GROWTH 169
TABLE 106 INCIDENCE OF TB (RATE PER 100,000 POPULATION) 170
TABLE 107 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 171
8.6 OTHER DISEASE INDICATIONS 171
TABLE 108 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 172
9 RESPIRATORY CARE DEVICES MARKET, BY END USER 173
9.1 INTRODUCTION 174
TABLE 109 RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 174
9.2 HOSPITALS 174
9.2.1 HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE RESPIRATORY CARE DEVICES MARKET DURING THE FORECAST PERIOD 174
TABLE 110 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 175
9.3 HOME CARE SETTINGS 176
9.3.1 RISING TECHNOLOGICAL ADVANCEMENTS HAVE LED TO THE DEVELOPMENT OF COMPACT & LIGHTWEIGHT DEVICES FOR HOME CARE 176
TABLE 111 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 177

9.4 AMBULATORY CARE CENTERS (ACCS) 177
9.4.1 GRADUAL SHIFT IN PATIENT PREFERENCES FOR ACCS OVER EXPENSIVE AND EXTENDED HOSPITAL STAYS 177
FIGURE 36 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005–2020) 178
TABLE 112 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 179
10 RESPIRATORY CARE DEVICES MARKET, BY REGION 180
10.1 INTRODUCTION 181
FIGURE 37 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT 181
TABLE 113 RESPIRATORY CARE DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 182
10.2 NORTH AMERICA 182
FIGURE 38 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 183
TABLE 114 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 183
TABLE 115 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 116 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 117 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 118 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 119 NORTH AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 120 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 121 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 122 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 123 NORTH AMERICA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 124 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 125 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 187
TABLE 126 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 127 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 128 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 129 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 188
TABLE 130 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 188

10.2.1 US 189
10.2.1.1 The US dominates the market in North America due to the high burden of asthma & COPD in the country 189
TABLE 131 US: KEY INDICATORS 189
TABLE 132 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 133 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 134 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 135 US: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 136 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 137 US: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 138 US: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 139 US: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 140 US: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 141 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 142 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 193
TABLE 143 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 144 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 145 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 146 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 194
TABLE 147 US: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 194
10.2.2 CANADA 195
10.2.2.1 The increasing incidence of COPD is driving the adoption of respiratory care devices in Canada 195
TABLE 148 CANADA: COPD AND ASTHMA STATISTICS (2019 VS 2020) 195
FIGURE 39 CANADA: ASTHMA PREVALENCE, BY AGE GROUP, 2017 VS. 2018 196
TABLE 149 CANADA: KEY INDICATORS 196
TABLE 150 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 197
TABLE 151 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 152 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 153 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 154 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 155 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 156 CANADA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 157 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 158 CANADA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 159 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 160 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 200
TABLE 161 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 162 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 163 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 164 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE/ DISORDERS, 2019–2026 (USD MILLION) 201
TABLE 165 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 201
10.3 EUROPE 202
FIGURE 40 EUROPE: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 202
TABLE 166 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 203
TABLE 167 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 168 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 169 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 170 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 171 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 172 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 173 EUROPE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 174 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 175 EUROPE: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 176 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 177 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 206
TABLE 178 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 179 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 180 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 181 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 208
TABLE 182 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 208
10.3.1 GERMANY 208
10.3.1.1 Increasing healthcare expenditure and strengthening of the healthcare infrastructure in Germany to drive market growth 208
TABLE 183 GERMANY: KEY INDICATORS 209
TABLE 184 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 209
TABLE 185 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 186 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 187 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 188 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 189 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 190 GERMANY: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 191 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 192 GERMANY: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 193 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 194 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 212
TABLE 195 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 196 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 197 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 198 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 214
TABLE 199 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 214
10.3.2 FRANCE 214
10.3.2.1 The high burden of COPD is due to the increasing tobacco consumption in the country to support the market growth 214
TABLE 200 FRANCE: KEY INDICATORS 215
TABLE 201 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 215
TABLE 202 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 203 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 204 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 205 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 206 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 207 FRANCE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 208 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 209 FRANCE: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 210 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 211 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 218
TABLE 212 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 213 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 214 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 215 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 220
TABLE 216 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 220
10.3.3 UK 220
10.3.3.1 The UK market has registered a favorable increase in healthcare expenditure, thus supporting the market growth 220
TABLE 217 UK: KEY INDICATORS 221
TABLE 218 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 221
TABLE 219 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 220 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 221 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 222 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 223 UK: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 224 UK: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 225 UK: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 226 UK: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 227 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 228 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 224
TABLE 229 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 225
TABLE 230 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 231 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 232 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 226
TABLE 233 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 226

10.3.4 ITALY 226
10.3.4.1 Unfavorable healthcare reforms may negatively impact the market in Italy for respiratory care devices 226
TABLE 234 ITALY: KEY INDICATORS 227
TABLE 235 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 227
TABLE 236 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 237 ITALY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 228
TABLE 238 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 239 ITALY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 240 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 241 ITALY: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 242 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 243 ITALY: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 244 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 245 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 246 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 247 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 248 ITALY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 249 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 232
TABLE 250 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 232
10.3.5 SPAIN 232
10.3.5.1 Increasing debt and shortcomings in the medical devices sector to restrain market growth in Spain 232
TABLE 251 SPAIN: KEY INDICATORS 233
TABLE 252 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 233
TABLE 253 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 254 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 255 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 256 SPAIN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 257 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 258 SPAIN: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 259 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 260 SPAIN: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 236
TABLE 261 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 236
TABLE 262 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 236
TABLE 263 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 264 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 237
TABLE 265 SPAIN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 237
TABLE 266 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 238
TABLE 267 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 238
10.3.6 REST OF EUROPE 238
TABLE 268 ROE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 239
TABLE 269 ROE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 239
TABLE 270 ROE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 271 ROE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 240
TABLE 272 ROE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 273 ROE: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 274 ROE: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 275 ROE: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 276 ROE: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 241
TABLE 277 ROE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 241
TABLE 278 ROE: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 242
TABLE 279 ROE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 280 ROE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 242
TABLE 281 ROE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 243
TABLE 282 ROE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 243
TABLE 283 ROE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 243
10.4 ASIA PACIFIC 244
FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 244
TABLE 284 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 245
TABLE 285 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 245
TABLE 286 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 246
TABLE 287 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 246
TABLE 288 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 289 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 290 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 291 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 292 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 293 ASIA PACIFIC: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 248
TABLE 294 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 248
TABLE 295 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 248
TABLE 296 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 297 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 298 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 299 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 250
TABLE 300 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 250
10.4.1 JAPAN 250
10.4.1.1 High accessibility to healthcare services supports the market growth in Japan 250
TABLE 301 JAPAN: KEY INDICATORS 251
TABLE 302 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 251
TABLE 303 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 304 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 305 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 252
TABLE 306 JAPAN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 307 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 308 JAPAN: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 309 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 310 JAPAN: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 254
TABLE 311 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 254
TABLE 312 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 254
TABLE 313 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 255
TABLE 314 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 255
TABLE 315 JAPAN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 255
TABLE 316 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 256
TABLE 317 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 256
10.4.2 CHINA 256
10.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for respiratory care devices in China 256
TABLE 318 CHINA: KEY INDICATORS 257
TABLE 319 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 257
TABLE 320 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 321 CHINA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 322 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 258
TABLE 323 CHINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 324 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 325 CHINA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 326 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 327 CHINA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 260
TABLE 328 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 260
TABLE 329 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 260
TABLE 330 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 261
TABLE 331 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 261
TABLE 332 CHINA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 261
TABLE 333 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 262
TABLE 334 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 262
10.4.3 INDIA 262
10.4.3.1 Rising patient population, healthcare expenditure, and medical tourism will favor the adoption of respiratory care devices in India 262
TABLE 335 INDIA: KEY INDICATORS 263
TABLE 336 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 264
TABLE 337 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 264
TABLE 338 INDIA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 339 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 340 INDIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 341 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 342 INDIA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 266
TABLE 343 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 266
TABLE 344 INDIA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 345 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 346 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 267
TABLE 347 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 267
TABLE 348 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 267
TABLE 349 INDIA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 350 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 268
TABLE 351 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 268
10.4.4 REST OF ASIA PACIFIC 269
TABLE 352 ROAPAC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 269
TABLE 353 ROAPAC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 270
TABLE 354 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 270
TABLE 355 ROAPAC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 356 ROAPAC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 357 ROAPAC: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 358 ROAPAC: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 359 ROAPAC: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 360 ROAPAC: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 361 ROAPAC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 362 ROAPAC: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 272
TABLE 363 ROAPAC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 364 ROAPAC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 365 ROAPAC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 366 ROAPAC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 274
TABLE 367 ROAPAC: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 274
10.5 LATIN AMERICA 274
TABLE 368 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 275
TABLE 369 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 275
TABLE 370 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 276
TABLE 371 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 372 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 373 LATIN AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 277
TABLE 374 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 277
TABLE 375 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 277
TABLE 376 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 277
TABLE 377 LATIN AMERICA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 378 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 278
TABLE 379 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 278
TABLE 380 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 381 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 382 LATIN AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 383 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 280
TABLE 384 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 280
10.5.1 BRAZIL 280
10.5.1.1 Healthcare infrastructural improvements to drive the market growth for respiratory care devices in Brazil 280
TABLE 385 BRAZIL: KEY INDICATORS 281
TABLE 386 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 281
TABLE 387 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 282
TABLE 388 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 282
TABLE 389 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 282
TABLE 390 BRAZIL: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 391 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 392 BRAZIL: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 393 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 394 BRAZIL: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 284
TABLE 395 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 396 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 284
TABLE 397 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 398 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 285
TABLE 399 BRAZIL: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 285
TABLE 400 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 286
TABLE 401 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 286
10.5.2 MEXICO 286
10.5.2.1 Rising obesity rate to increase the incidence of respiratory diseases in Mexico 286
TABLE 402 MEXICO: KEY INDICATORS 287
TABLE 403 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 287
TABLE 404 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 288
TABLE 405 MEXICO: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 288
TABLE 406 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 407 MEXICO: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 408 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 409 MEXICO: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 410 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 411 MEXICO: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 412 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 290
TABLE 413 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 290
TABLE 414 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 291
TABLE 415 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 291
TABLE 416 MEXICO: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 291
TABLE 417 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 292
TABLE 418 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 292
10.5.3 REST OF LATIN AMERICA (ROLATAM) 292
TABLE 419 ROLATAM: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 293
TABLE 420 ROLATAM: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 293
TABLE 421 ROLATAM: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 294
TABLE 422 ROLATAM: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 294
TABLE 423 ROLATAM: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 294
TABLE 424 ROLATAM: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 294
TABLE 425 ROLATAM: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 426 ROLATAM: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 427 ROLATAM: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 295
TABLE 428 ROLATAM: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 429 ROLATAM: PULSE OXIMETERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 296
TABLE 430 ROLATAM: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 431 ROLATAM: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 432 ROLATAM: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 297
TABLE 433 ROLATAM: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 297
TABLE 434 ROLATAM: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 297
10.5.4 MIDDLE EAST & AFRICA 298
10.5.4.1 Growing geriatric population to drive growth in the Middle East & Africa region 298
TABLE 435 MEA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 298
TABLE 436 MEA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 299
TABLE 437 MEA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 299
TABLE 438 MEA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 299
TABLE 439 MEA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 300
TABLE 440 MEA: ICU VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 300
TABLE 441 MEA: INHALERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 300
TABLE 442 MEA: HUMIDIFIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 300
TABLE 443 MEA: REUSABLE RESUSCITATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 301
TABLE 444 MEA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 301
TABLE 445 MEA: PULSE OXIMETERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 301
TABLE 446 MEA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 302
TABLE 447 MEA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 302
TABLE 448 MEA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 302
TABLE 449 MEA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATIONS, 2019–2026 (USD MILLION) 303
TABLE 450 MEA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 303
11 COMPETITIVE LANDSCAPE 304
11.1 INTRODUCTION 304
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 304
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY THE PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET 305
11.3 REVENUE SHARE ANALYSIS 306
11.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET 306
FIGURE 42 REVENUE ANALYSIS FOR KEY PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET IN THE PAST FIVE YEARS 306
11.4 MARKET SHARE ANALYSIS 307
11.4.1 RESPIRATORY CARE DEVICES MARKET (2020) 307
FIGURE 43 SHARE OF LEADING COMPANIES IN THE GLOBAL RESPIRATORY CARE DEVICES MARKET (2020) 307
FIGURE 44 PHILIPS HEALTHCARE: MARKET LEADER IN THE VENTILATORS MARKET, 2020 309
FIGURE 45 SHARE OF LEADING COMPANIES IN THE GLOBAL CPAP MARKET (2020) 309
FIGURE 46 PULSE OXIMETERS MARKET SHARE, BY KEY PLAYER, 2020 310
FIGURE 47 SPIROMETERS MARKET RANKING, BY KEY PLAYER, 2020 310
TABLE 451 RESPIRATORY CARE DEVICES MARKET: DEGREE OF COMPETITION 311
11.5 GEOGRAPHICAL ASSESSMENT OF THE MAJOR PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET 312
11.6 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE 313
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN THE RESPIRATORY CARE DEVICES MARKET, 2019 VS. 2020 (USD MILLION) 313
11.7 COMPETITIVE LEADERSHIP MAPPING 313
11.7.1 STARS 314
11.7.2 EMERGING LEADERS 314
11.7.3 PERVASIVE PLAYERS 314
11.7.4 PARTICIPANTS 314
FIGURE 49 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 315
11.8 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2020) 316
11.8.1 PROGRESSIVE COMPANIES 316
11.8.2 DYNAMIC COMPANIES 316
11.8.3 STARTING BLOCKS 316
11.8.4 RESPONSIVE COMPANIES 316
FIGURE 50 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2020 317
11.9 COMPETITIVE BENCHMARKING 318
FIGURE 51 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 318
TABLE 452 COMPANY SERVICE OFFERING FOOTPRINT (25 COMPANIES) 319
TABLE 453 COMPANY INDICATION FOOTPRINT (25 COMPANIES) 320
TABLE 454 COMPANY END-USER FOOTPRINT (25 COMPANIES) 321

11.10 COMPETITIVE SITUATIONS AND TRENDS 322
11.10.1 PRODUCT LAUNCHES 322
11.10.2 OTHER DEVELOPMENTS 323
11.10.3 DEALS 323
12 COMPANY PROFILES 325
12.1 KEY PLAYERS 325
(Business overview, Products and services offered, Recent Developments, MNM view)*
12.1.1 PHILIPS HEALTHCARE 325
TABLE 455 PHILIPS HEALTHCARE: BUSINESS OVERVIEW 325
FIGURE 52 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2020) 326
FIGURE 53 QUARTERLY REVENUE ANALYSIS: PHILIPS (CONNECTED CARE) 331
12.1.2 MEDTRONIC PLC 332
TABLE 456 MEDTRONIC PLC: BUSINESS OVERVIEW 332
FIGURE 54 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 333
FIGURE 55 QUARTERLY REVENUE ANALYSIS: MEDTRONIC (RGR) 337
12.1.3 RESMED, INC. 338
TABLE 457 RESMED, INC.: BUSINESS OVERVIEW 338
FIGURE 56 RESMED, INC.: COMPANY SNAPSHOT (2020) 339
FIGURE 57 QUARTERLY REVENUE ANALYSIS: RESMED, INC. 344
12.1.4 MASIMO CORPORATION 345
TABLE 458 MASIMO CORPORATION: BUSINESS OVERVIEW 345
FIGURE 58 MASIMO CORPORATION: COMPANY SNAPSHOT (2020) 345
12.1.5 FISHER & PAYKEL HEALTHCARE CO. LTD. 350
TABLE 459 FISHER & PAYKEL HEALTHCARE CO. LTD.: BUSINESS OVERVIEW 350
FIGURE 59 FISHER & PAYKEL HEALTHCARE CO. LTD.: COMPANY SNAPSHOT (2020) 351
12.1.6 DRÄGERWERK AG & CO. 356
TABLE 460 DRÄGERWERK AG & CO.: BUSINESS OVERVIEW 356
FIGURE 60 DRÄGERWERK AG & CO.: COMPANY SNAPSHOT (2020) 357
FIGURE 61 QUARTERLY REVENUE ANALYSIS: DRÄGERWERK AG & CO.
(MEDICAL DIVISION) 360
12.1.7 GETINGE AB 361
TABLE 461 GETINGE AB: BUSINESS OVERVIEW 361
FIGURE 62 GETINGE AB: COMPANY SNAPSHOT (2020) 362
FIGURE 63 QUARTERLY REVENUE ANALYSIS: GETINGE AB (ACUTE CARE THERAPIES) 364
12.1.8 NIHON KOHDEN CORPORATION 365
TABLE 462 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 365
FIGURE 64 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 366
12.1.9 GENERAL ELECTRIC HEALTHCARE (GE ELECTRIC) 369
TABLE 463 GENERAL ELECTRIC: BUSINESS OVERVIEW 369
FIGURE 65 GENERAL ELECTRIC: COMPANY SNAPSHOT (2020) 370

12.1.10 VYAIRE MEDICAL 372
TABLE 464 VYAIRE MEDICAL: BUSINESS OVERVIEW 372
12.1.11 HILL-ROM, INC. 376
TABLE 465 HILL-ROM, INC.: BUSINESS OVERVIEW 376
FIGURE 66 HILL-ROM, INC.: COMPANY SNAPSHOT: COMPANY SNAPSHOT (2020) 376
12.1.12 ADAPTHEALTH, LLC. 379
TABLE 466 ADAPTHEALTH, LLC.: BUSINESS OVERVIEW 379
FIGURE 67 ADAPTHEALTH, LLC.: COMPANY SNAPSHOT (2020) 379
12.1.13 ROTECH HEALTHCARE, INC. 381
TABLE 467 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW 381
FIGURE 68 ROTECH HEALTHCARE INC.: COMPANY SNAPSHOT (2020) 381
12.1.14 TELEFLEX INCORPORATED 383
TABLE 468 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 383
FIGURE 69 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 384
12.1.15 AIR LIQUIDE 386
TABLE 469 AIR LIQUIDE: BUSINESS OVERVIEW 386
FIGURE 70 AIR LIQUIDE: COMPANY SNAPSHOT (2020) 387
12.2 OTHER PLAYERS 390
12.2.1 INVACARE CORPORATION 390
TABLE 470 INVACARE CORPORATION: BUSINESS OVERVIEW 390
FIGURE 71 INVACARE CORPORATION: COMPANY SNAPSHOT (2020) 391
12.2.2 SMITHS MEDICAL 393
TABLE 471 SMITHS MEDICAL: BUSINESS OVERVIEW 393
FIGURE 72 SMITHS MEDICAL: COMPANY SNAPSHOT (2020) 394
12.2.3 HAMILTON MEDICAL AG 397
TABLE 472 HAMILTON MEDICAL AG: BUSINESS OVERVIEW 397
12.2.4 APEX MEDICAL CORPORATION 400
TABLE 473 APEX MEDICAL CORPORATION: BUSINESS OVERVIEW 400
12.2.5 MEDLINE INDUSTRIES, INC. 402
TABLE 474 MEDLINE INDUSTRIES, INC.: BUSINESS OVERVIEW 402
12.2.6 HUM GMBH 405
TABLE 475 HUM GMBH: BUSINESS OVERVIEW 405
12.2.7 NONIN 407
12.2.8 ALLIED HEALTHCARE PRODUCTS, INC. 408
12.2.9 DRIVE DEVILBISS HEALTHCARE 409
12.2.10 OMRON HEALTHCARE, INC. 410
*Details on Business overview, Products and services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 411
13.1 DISCUSSION GUIDE 411
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 418
13.3 AVAILABLE CUSTOMIZATIONS 420
13.4 RELATED REPORTS 420
13.5 AUTHOR DETAILS 421

★調査レポート[呼吸ケア装置の世界市場予測:製品別、エンドユーザー別] ( Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast to 2026 / MD1583) 販売に関する免責事項
[呼吸ケア装置の世界市場予測:製品別、エンドユーザー別] ( Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast to 2026 / MD1583) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆